1 results match your criteria: "and Interfaculty Center of Pharmacogenomic and Drug Research[Affiliation]"

Targeting Gα in neutrophils protects from myocardial ischemia reperfusion injury.

Basic Res Cardiol

October 2024

Department of Pharmacology, Experimental Therapy and Toxicology, Institute for Experimental and Clinical Pharmacology and Pharmacogenomic, Eberhard Karls University, and Interfaculty Center of Pharmacogenomic and Drug Research, Wilhelmstrasse 56, 72074, Tübingen, Germany. sandra.beer-hammer@uni-tue

Neutrophils are not only involved in immune defense against infection but also contribute to the exacerbation of tissue damage after ischemia and reperfusion. We have previously shown that genetic ablation of regulatory Gα proteins in mice has both protective and deleterious effects on myocardial ischemia reperfusion injury (mIRI), depending on which isoform is deleted. To deepen and analyze these findings in more detail the contribution of Gα proteins in resident cardiac vs circulating blood cells for mIRI was first studied in bone marrow chimeras.

View Article and Find Full Text PDF